Author Affiliations: Department of Cardiology, Santa Maria University Hospital, Centro Hospitalar Lisboa Norte, Lisbon, Portugal.
Although the prevalence of rheumatic fever has greatly decreased in developed countries, rheumatic mitral stenosis still causes significant morbidity and mortality. Symptomatic patients have a poor prognosis, with a 0 to 15% 10-year survival rate, particularly if percutaneous or surgical intervention are contraindicated or considered high risk. We present a case of severe rheumatic mitral stenosis with an evolution over 4 decades, in which exceptional venous distention has established.
Carrilho-Ferreira P, Pedro MM, Varela MG, Diogo AN. Severe Rheumatic Mitral Stenosis: A 21st Century Medusa. Arch Intern Med. 2011;171(16):1498–1499. doi:10.1001/archinternmed.2011.368
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: